Speaker tour

 

The Changing Landscape in CML Therapy: New Treatment Goals and Choices 5/5 (1)

Timothy Hughes, MD, FRACP, FRCPA
Head of the Department of Hematology at IMVS (RAH site)
Consultant Hematologist
Royal Adelaide Hospital
Australia
 

The Changing CML Treatment Paradigm 4/5 (2)

Giuseppe Saglio, MD, PhD
Professor of Hematology
University of Turin
Ospedale Mauriziano-Torino
Turin, Italy
MPN

The latest information on myeloproliferative neoplasms No ratings yet.

Attilio Orazi, MD, FRCPath. (Angl.)
Weill Cornell Medical College
New York Presbyterian Hospital
New York, NY, USA